eHealth Q2 revenue down 10%, net income falls 75%.

• eHealth reports Q2 2025 financial results • Webcast and conference call scheduled for August 6, 2025 • Investors can dial (800) 549-8228 to listen • Live and archived webcast available on the company's website

eHealth Inc. (NASDAQ: EHTH) is set to release its Q2 2025 financial results on Wednesday, August 6, 2025, before the market opens. The company will host a webcast and conference call to discuss the earnings, and investors can dial (800) 549-8228 to listen. The live and archived webcast will also be available on the company's website.

Analysts expect eHealth's revenue to decline by 29.5% year-over-year (YoY) to $46.41 million, a further deceleration from the 1.4% decrease recorded in the same quarter last year. The adjusted loss is expected to come in at -$1.25 per share [1]. Despite these expectations, eHealth has a history of exceeding Wall Street’s expectations, beating revenue estimates every single time over the past two years by an average of 13.1% [1].

eHealth reported 1.16 million users in Q1 2025, down 1.8% YoY. The company's peers in the online marketplace segment have shown varying performances. Shutterstock delivered year-on-year revenue growth of 21.3%, beating analysts’ expectations by 7.5%, while EverQuote reported revenues up 33.7%, in line with consensus estimates [1].

Investors in the online marketplace segment have had steady hands going into earnings, with share prices up 1.5% on average over the last month. However, eHealth is down 22.5% during the same time and is heading into earnings with an average analyst price target of $10, compared to the current share price of $3.21 [1].

Avantor Inc. (AVTR), a global provider of essential products and services for the life sciences and advanced technology sectors, released its Q2 2025 financial results. The company reported net sales of $1.68 billion, a 1% decrease year-over-year (YoY), and net income of $65 million. The adjusted EBITDA stood at $280 million, with an adjusted earnings per share (EPS) of $0.24 [2].

Management remains optimistic about navigating near-term challenges and delivering long-term value to shareholders. The company expects full-year organic revenue growth to be between negative 2% and flat, with adjusted EBITDA margins between 16.5% and 17%. Free cash flow expectations are revised to $550 million to $600 million before transformation expenses [2].

eHealth's performance in Q2 2025 will be closely watched by investors and analysts. The company's ability to meet or exceed expectations will be crucial in determining its future trajectory.

References:
[1] https://finance.yahoo.com/news/ehealth-ehth-q2-earnings-report-030335287.html
[2] https://www.ainvest.com/news/avantor-reports-q2-2025-financial-results-net-sales-1-1-68-billion-2508/